122 related articles for article (PubMed ID: 2220657)
41. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
42. Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer. A randomized phase II study.
Popov IP; Jelić SB; Krivokapić ZV; Jezdić SD; Pesko PM; Micev MT; Babić DR
Med Oncol; 2008; 25(1):73-80. PubMed ID: 17972024
[TBL] [Abstract][Full Text] [Related]
43. [A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy].
Inaba Y; Chiba M; Watabe S; Kudo K; Hayashi K; Otsuka S
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2421-3. PubMed ID: 1463349
[TBL] [Abstract][Full Text] [Related]
44. [The effect of EAP (etoposide, adriamycin, cis-platinum) on patients with advanced gastric cancer: the role of EAP as neoadjuvant chemotherapy and histopathological study on its effect].
Tsujinaka T; Murata A; Ogawa M; Kido Y; Shiozaki H; Miyamoto T; Kanbayashi J; Kobayashi K; Tahara H; Miyata M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3295-8. PubMed ID: 2782922
[No Abstract] [Full Text] [Related]
45. [Effect of high dose etoposide, adriamycin, cisplatin (EAP) therapy with autologous bone marrow transplantation in gastric cancer].
Suzuki T; Ochiai T; Ozaki M; Asano T; Koide Y; Gunji Y; Shu S; Hori S; Nabeya Y; Isono K
Gan To Kagaku Ryoho; 1990 May; 17(5):1069-72. PubMed ID: 2334173
[TBL] [Abstract][Full Text] [Related]
46. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
47. A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Rose PG; Rodriguez M; Walker J; Greer B; Fusco N; McGuire W
Gynecol Oncol; 2002 Apr; 85(1):136-9. PubMed ID: 11925133
[TBL] [Abstract][Full Text] [Related]
48. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Di Bartolomeo M; Buzzoni R; Mariani L; Ferrario E; Katia D; Gevorgyan A; Zilembo N; Bordonaro R; Bochicchio AM; Massidda B; Ardizzoia A; Marini G; Aitini E; Schieppati G; Comella G; Pinotti G; Palazzo S; Cicero G; Bajetta E; ; Villa E; Fagnani D; Reguzzoni G; Agostana B; Oliani C; Kildani B; Duro M; Botta M; Mozzana R; Mantovani G
Oncology; 2006; 71(5-6):341-6. PubMed ID: 17855795
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).
Roth AD; Herrmann R; Morant R; Borner MM; Honegger HP; Obrist R; Bacchi M; Lange J; Alberto P; Castiglione M
Eur J Cancer; 1998 Dec; 34(13):2126-8. PubMed ID: 10070322
[TBL] [Abstract][Full Text] [Related]
50. [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy].
Uchinami M; Horiuchi T; Aotake T; Matsumura M; Yokomachi J; Tanaka K; Tabo T; Tanigawa N
Gan To Kagaku Ryoho; 2002 Mar; 29(3):449-53. PubMed ID: 11915738
[TBL] [Abstract][Full Text] [Related]
51. Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer.
Fanning J; Hilgers RD
Gynecol Oncol; 1996 Dec; 63(3):323-7. PubMed ID: 8946866
[TBL] [Abstract][Full Text] [Related]
52. The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case.
Tahara H; Ogawa M; Kido Y; Shiozaki H; Ohashi I; Mori T; Sakurai M
Jpn J Surg; 1991 Jul; 21(4):433-7. PubMed ID: 1960901
[TBL] [Abstract][Full Text] [Related]
53. Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer.
Sparano JA; Wiernik PH
J Clin Oncol; 1990 May; 8(5):938-9. PubMed ID: 2332775
[No Abstract] [Full Text] [Related]
54. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
55. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
[TBL] [Abstract][Full Text] [Related]
56. Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.
Chung HC; Roh JK; Park YJ; Lee SI; Min JS; Lee JT; Lee KB; Kim BS
Yonsei Med J; 1990 Mar; 31(1):74-9. PubMed ID: 2346043
[TBL] [Abstract][Full Text] [Related]
57. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659
[TBL] [Abstract][Full Text] [Related]
58. Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: a prospective randomised trial.
Popov I; Jelić S; Radulović S; Radosavljević D; Nikolić-Tomasević Z
Ann Oncol; 2000 Mar; 11(3):343-8. PubMed ID: 10811503
[TBL] [Abstract][Full Text] [Related]
59. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
60. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]